Header cover image

Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED Jul 03, 2022

Companies with a Value score of at least 3, ordered by Value score

33 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
NOVNNovartisCHF80.33-0.3%-5.0%CHF174.5bCHF91.19PE7.5xE2.8%3.7%
TECNTecan GroupCHF285.80-0.4%-38.9%CHF3.6bCHF494.33PE29.9xE13.0%1.0%
QGENQiagenUS$48.850%17.9%US$10.9bUS$57.50PE20.2xE7.0%n/a
935700Gilead SciencesUS$55.820%-25.6%US$78.2bUS$62.34PE17.3xE8.3%4.7%
1102657GSKUK£21.420%-0.4%UK£90.4bUK£22.42PE17.7xE10.4%4.5%
ESFEurofins Scientific€505.000%0.08%€14.5b€691.99PE19.3xE-0.2%1.3%
907582AmgenUS$227.360%26.4%US$131.2bUS$228.25PE22.9xE9.7%3.2%
COPNCosmo PharmaceuticalsCHF46.701.5%-45.2%CHF780.2mCHF85.90PE36xE46.7%2.0%
MOLNMolecular PartnersCHF6.59-7.2%-64.7%CHF214.2mCHF26.81PE2xE-74.0%n/a
BIIBBiogenUS$220.000%0%US$30.8bUS$253.58PE21.3xE2.3%n/a
SFZNSiegfried HoldingCHF624.50-0.2%-28.7%CHF2.7bCHF861.03PE27.7xE12.0%0.5%
10683053MerckUS$87.25-1.1%5.6%US$233.7bUS$91.19PE16.8xE11.8%3.0%
NOVNEENovartisCHF80.23-0.3%-6.1%CHF174.5bCHF91.07PE7.5xE2.8%3.7%
NWRNNewron PharmaceuticalsCHF1.45-5.2%-43.1%CHF25.9mCHF9.25PS4.5xE54.6%n/a
TEVATeva Pharmaceutical IndustriesUS$7.850%0%US$8.8bUS$9.84PB0.9xE105.1%0%
GXIGerresheimer€75.600%0%€1.8b€119.42PE21.3xE20.9%2.2%
RORoche HoldingCHF372.002.8%-2.0%CHF262.0bCHF448.47PE18.4xE7.4%2.9%
ROGRoche HoldingCHF320.400.5%-8.3%CHF262.0bCHF386.26PE18.4xE7.4%2.9%
943981Johnson & JohnsonUS$170.060%21.5%US$472.4bUS$177.41PE23.8xE4.4%2.5%
BMYBristol-Myers SquibbUS$54.240%22.2%US$163.6bUS$55.80PE26.2xE14.0%2.8%
UNCUCB€111.210%n/a€15.6b€147.29PE14.8xE9.5%1.6%
982352AstraZenecaUK£117.490%23.7%UK£166.6bUK£129.35PS4.8xE27.5%2.0%
VRXBausch Health CompaniesUS$24.110%0%US$3.1bUS$76.60PE-7.6xE48.2%0%
WBIOWockhardt BioCHF1.5817.0%n/aCHF82.1mn/aPE2.3xn/a0%
Page 1 of 2